It’s tricky to say. Technically, it’s not - but, news coverage about the progress of the psychedelic movement often mentions MDMA. In many ways, MAPS (The Multidisciplinary Association for Psychedelic Studies - a pioneering psychedelic research nonprofit who we are in collaboration with - has made it a treatment that they are investing heavily in to make it the first drug they get to market for PTSD. It can enhance colors and sounds, but isn’t known to cause full-blown hallucinations. It also can be compared to more classic psychedelics - like LSD and mushrooms - because it can reduce fear and defensiveness, enhance communication and introspection, and increase empathy and compassion, enhancing the therapeutic process for people suffering from PTSD.⁠ This is why it’s most suited to be grouped with psychedelics, even though it isn’t one. Working with MDMA in the right setting, with the right therapist, can be life-changing.